Title
Category
Credits
Event date
Cost
  • Alabama Community Engagement Alliance against COVID-19 Disparities (Alabama CEAL)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
$0.00
  • Live @ Lunch
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
$25.00
LIVE @ LUNCH - HFpEF: Time for a Deeper Look webinar is part of our LIVE @ LUNCH Webinar Subscription. There are five 1-hour courses included in this webinar series and each can be purchased separately for $25 each. If you are interested in signing up for the $100 webinar subscription for all 5 LIVE @ LUNCH programs, you may do so by clicking on the following link below and will receive a code to register for all 2024 Live @ Lunch webinars.
  • On-Demand
  • 1.00 ACPE Pharmacy
$25.00
Family planning and contraceptive care have recently been debated within the state of Alabama . The Supreme Court of Alabama's February ruling that cryogenic IVF embryos be recognized as children and entitled to legal protection has resulted in bills proposing civil and criminal immunity for IVF facilities (S 159) and protecting access to contraceptive care (HB 279).
  • On-Demand
  • 1.00 ACPE Pharmacy
$25.00
This presentation will provide attendees with an update on key changes in COPD over the past 5 years.
  • On-Demand
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
$25.00
This presentation will describe the basics of Medicare and Medicaid, financial assistance programs for older adults, and how to protect older adults from Medicare fraud.
  • On-Demand
  • 1.00 ACPE Pharmacy
$25.00
This presentation will cover the essentials of drug interactions (recognize, evaluate, mitigate) with specific focus on drug-drug and drug disease interactions in older adults (i.e. 65 years of age or older). Older adults are more likely than younger adults to take numerous concomitant medications and have multiple comorbidities, increasing their risk of drug interactions and subsequent adverse drug events.
  • On-Demand
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
$25.00
Chronic coronary disease (CCD), formerly known as "stable ischemic heart disease," encompasses a diverse range of conditions, including both obstructive and nonobstructive coronary artery disease (CAD), with or without a history of myocardial infarction (MI) or revascularization. It also includes ischemic heart disease diagnosed solely through noninvasive testing and chronic angina syndromes arising from various underlying causes. Approximately 20 million people in the United States live with CCD, and it remains a leading cause of death.
  • AUHCOP Preceptor Resources
  • 3.00 ACPE Pharmacy
$100.00
This preceptor development program was developed to educate and assist preceptors with effective precepting techniques, understanding statues and rules for preceptors in the state of AL, providing feedback on student performance, applying strategies for dealing with difficult learning situations and enhancing student preparation for licensing exams. Engaging material will include interactive lectures, group discussions, and real-world examples.This program has been approved by the Alabama Board of Pharmacy for continuing education credit to meet Preceptor licensure requirements.
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
National and Alabama use patterns & trends will be discussed including data from treatment admissions. Risk factors and DSM criteria along with prevalence and epidemiology will be reviewed. A description of available products and relative potency. We will review heavily utilized alternatives like delta-8 and/or delta-10 along with their legal status. We will review in detail the new AL Medical Cannabis Use from the Alabama Compassion Act in 2021 that will be implemented starting 9/1/22. 
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 ACPE Technician
  • 0.25 ABO
  • 0.25 ABP
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the importance of taking a multidisciplinary, patient centered approach to substance use disorder treatment.

Pages